Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Human immunodeficiency virus type 2.

Reeves JD, Doms RW.

J Gen Virol. 2002 Jun;83(Pt 6):1253-65. Review. No abstract available.

PMID:
12029140
[PubMed - indexed for MEDLINE]
Free Article
2.

Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.

Willey SJ, Reeves JD, Hudson R, Miyake K, Dejucq N, Schols D, De Clercq E, Bell J, McKnight A, Clapham PR.

J Virol. 2003 Jun;77(11):6138-52.

PMID:
12743271
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.

Cayabyab M, Rohne D, Pollakis G, Mische C, Messele T, Abebe A, Etemad-Moghadam B, Yang P, Henson S, Axthelm M, Goudsmit J, Letvin NL, Sodroski J.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):27-40.

PMID:
15000696
[PubMed - indexed for MEDLINE]
4.

Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

König RR, Flory E, Steidl S, Neumann J, Coulibaly C, Holznagel E, Holzammer S, Norley S, Cichutek K.

J Virol. 2002 Nov;76(21):10627-36.

PMID:
12368305
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
[PubMed - indexed for MEDLINE]
6.

Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.

Doms RW, Peiper SC.

Virology. 1997 Sep 1;235(2):179-90. Review. No abstract available.

PMID:
9281497
[PubMed - indexed for MEDLINE]
Free Article
7.

Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.

Shi Y, Brandin E, Vincic E, Jansson M, Blaxhult A, Gyllensten K, Moberg L, Broström C, Fenyö EM, Albert J.

J Gen Virol. 2005 Dec;86(Pt 12):3385-96.

PMID:
16298986
[PubMed - indexed for MEDLINE]
Free Article
8.

Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.

Santos-Costa Q, Mansinho K, Moniz-Pereira J, Azevedo-Pereira JM.

Virus Res. 2009 Jun;142(1-2):41-50. doi: 10.1016/j.virusres.2009.01.012. Epub 2009 Feb 4.

PMID:
19200444
[PubMed - indexed for MEDLINE]
9.

Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A.

Virology. 2004 Jan 5;318(1):55-65.

PMID:
14972535
[PubMed - indexed for MEDLINE]
10.

R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Tasca S, Ho SH, Cheng-Mayer C.

J Virol. 2008 Jul;82(14):7089-99. doi: 10.1128/JVI.00570-08. Epub 2008 May 14.

PMID:
18480460
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo.

Bhattacharya J, Peters PJ, Clapham PR.

AIDS. 2003;17 Suppl 4:S35-43. Review. No abstract available.

PMID:
15080178
[PubMed - indexed for MEDLINE]
12.

Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.

Tuttle DL, Coberley CR, Xie X, Kou ZC, Sleasman JW, Goodenow MM.

AIDS Res Hum Retroviruses. 2004 Mar;20(3):305-13.

PMID:
15117454
[PubMed - indexed for MEDLINE]
13.

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.

Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW.

J Infect Dis. 2005 Mar 15;191(6):890-8. Epub 2005 Feb 9.

PMID:
15717264
[PubMed - indexed for MEDLINE]
Free Article
14.

Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus.

Reyes RA, Canfield DR, Esser U, Adamson LA, Brown CR, Cheng-Mayer C, Gardner MB, Harouse JM, Luciw PA.

J Virol. 2004 Feb;78(4):2121-30.

PMID:
14747577
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.

Willey S, Peters PJ, Sullivan WM, Dorr P, Perros M, Clapham PR.

Antiviral Res. 2005 Nov;68(2):96-108. Epub 2005 Aug 30.

PMID:
16157392
[PubMed - indexed for MEDLINE]
16.

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.

Moore JP, Kitchen SG, Pugach P, Zack JA.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):111-26. Review.

PMID:
15000703
[PubMed - indexed for MEDLINE]
17.

Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5.

Dolcini G, Derrien M, Chaouat G, Barré-Sinoussi F, Menu E.

AIDS Res Hum Retroviruses. 2003 Oct;19(10):857-64.

PMID:
14585217
[PubMed - indexed for MEDLINE]
18.

Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.

Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.

J Clin Virol. 2008 Sep;43(1):25-31. doi: 10.1016/j.jcv.2008.03.026. Epub 2008 May 6.

PMID:
18462992
[PubMed - indexed for MEDLINE]
19.

Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4.

Michler K, Connell BJ, Venter WD, Stevens WS, Capovilla A, Papathanasopoulos MA.

AIDS Res Hum Retroviruses. 2008 May;24(5):743-51. doi: 10.1089/aid.2007.0304.

PMID:
18507530
[PubMed - indexed for MEDLINE]
20.

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM.

Clin Infect Dis. 2007 Feb 15;44(4):591-5. Epub 2007 Jan 17. Erratum in: Clin Infect Dis. 2007 May 15;44(10):1399.

PMID:
17243065
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk